Peter J. Boström

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

Girish S. Kulkarni, Thomas Hermanns, Yanliang Wei et al. · Journal of Clinical Oncology · 2017 · 307 citations · Full text

Medicine, Oncology, Surgery +14

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage

Bas W.G. van Rhijn, Theodorus van der Kwast, Sultan S. Alkhateeb et al. · European Urology · 2011 · 191 citations

Medicine, Oncology, Urology +14

Risk factors for mortality and morbidity related to radical cystectomy

Peter J. Boström, Jyrki Kössi, Matti Laato et al. · British Journal of Urology · 2008 · 143 citations

Medicine, Anesthesiology, Surgery +13

Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi‐institutional study

Shoshana B. Ginsburg, Ahmad Algohary, Shivani Pahwa et al. · Journal of Magnetic Resonance Imaging · 2016 · 142 citations · Full text

Medicine, Oncology, Radiology +17